3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
71
Pancreatic Neoplasms
69
Colorectal Neoplasms
26
Liver Neoplasms
20
Neoplasm Metastasis
9
Lung Neoplasms
8
Melanoma
7
Cholangiocarcinoma
6
Sarcoma
5
Neoplasms
5
Colonic Neoplasms
5
Breast Neoplasms
5
Stomach Neoplasms
4
Gastrointestinal Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Klatskin Tumor
3
Urinary Bladder Neoplasms
2
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Locally Advanced Pancreatic Cancer
2
Carcinoma, Non-Small-Cell Lung
2
Bile Duct Neoplasms
2
Adrenal Gland Neoplasms
2
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Spinal Cord Compression
1
Interventions
Gemcitabine
4
Leucovorin
2
Fluorouracil
2
tremelimumab
1
pamrevlumab
1
irinotecan sucrosofate
1
folfirinox
1
durvalumab
1
Taxes
1
Specimen Handling
1
Radiosurgery
1
Oxaliplatin
1
Medical Marijuana
1
Irinotecan
1
Heavy Ion Radiotherapy
1
Chemoradiotherapy
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Cancer Non-resectable
×
Radiosurgery
×
Gastrointestinal
×
Clear all
NCT03964064
2019-07-19
Ckvssip
Peking University Third Hospital
Phase NA
Unknown
100 enrolled